DGK-β Inhibitors
DGK-β inhibitors constitute a chemical class of compounds that can interact with and modulate the activity of diacylglycerol kinase beta (DGK-β), an enzyme responsible for the phosphorylation of diacylglycerol (DAG) to produce phosphatidic acid (PA). These inhibitors include both direct and indirect modulators of the enzyme's function. Direct inhibitors bind to the active site or allosteric sites on the enzyme, thereby preventing its interaction with DAG, while indirect inhibitors act on upstream or downstream pathways that influence DGK-β activity.
The chemical class of DGK-β inhibitors encompasses a wide variety of compounds with diverse structures and modes of action. Some of these chemicals act by influencing the levels of DAG, the natural substrate for DGK-βUnfortunately, there is no comprehensive list of direct inhibitors for DGK-β (diacylglycerol kinase beta) with associated CAS numbers and detailed mechanisms of action.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium can inhibit the phosphoinositide cycle, which is upstream of DGK activity. By altering phosphoinositide turnover, lithium can indirectly affect DGK-β activity by changing the availability of its substrate. | ||||||
Calphostin C | 121263-19-2 | sc-3545 sc-3545A | 100 µg 1 mg | $343.00 $1642.00 | 20 | |
Calphostin C inhibits protein kinase C (PKC), which is downstream of DGK activity. Inhibition of PKC can lead to increased DAG levels, which can saturate DGK-β and reduce its activity indirectly. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Similar to R59022, R59949 is a general DGK inhibitor. By preventing the phosphorylation of DAG, it can indirectly modulate DGK-β activity by influencing the cellular levels of its substrates and products. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and can influence signaling pathways that involve DGK-β. Alterations in microtubule dynamics can indirectly affect DGK-β localization and function. | ||||||
D-erythro-Sphingosine | 123-78-4 | sc-3546 sc-3546A sc-3546B sc-3546C sc-3546D sc-3546E | 10 mg 25 mg 100 mg 1 g 5 g 10 g | $90.00 $194.00 $510.00 $2448.00 $9384.00 $15300.00 | 2 | |
Sphingosine can act as an inhibitor of protein kinase C, which is involved in the same pathways as DGK-β. By inhibiting PKC, sphingosine can raise DAG levels and indirectly influence DGK-β activity. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Gö 6983 is a broad-spectrum protein kinase C inhibitor. It can influence DGK-β activity by preventing PKC-mediated phosphorylation events that could be necessary for DGK-β function. | ||||||
C2 Ceramide | 3102-57-6 | sc-201375 sc-201375A | 5 mg 25 mg | $124.00 $460.00 | 12 | |
Ceramide activates protein phosphatases and can inhibit protein kinase C. By affecting these enzymes, ceramide can modulate the turnover of DAG and indirectly influence DGK-β activity. | ||||||